Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Prepaid Assets (2024 - 2025)

Prelude Therapeutics' Prepaid Assets history spans 2 years, with the latest figure at $2.5 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 8.64% year-over-year to $2.5 million; the TTM value through Dec 2025 reached $2.5 million, up 8.64%, while the annual FY2025 figure was $2.5 million, 8.64% up from the prior year.
  • Prepaid Assets for Q4 2025 was $2.5 million at Prelude Therapeutics, down from $3.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $3.7 million in Q2 2025 and bottomed at $2.3 million in Q4 2024.